Stablecoin Development Corporation (SDEV)

NYSEAMERICAN: SDEV · Real-Time Price · USD
1.270
-0.040 (-3.05%)
At close: May 29, 2026, 4:00 PM EDT
1.240
-0.030 (-2.36%)
After-hours: May 29, 2026, 8:00 PM EDT
Market Cap63.22M +1,750.2%
Revenue (ttm)25.14M
Net Income522.59M +14,174.6%
EPS11.11 +292.6%
Shares Out 49.78M
PE Ratio0.11
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume123,659
Open1.330
Previous Close1.310
Day's Range1.250 - 1.360
52-Week Range1.110 - 99.750
Beta0.07
Analystsn/a
Price Targetn/a
Earnings DateMay 15, 2026

About SDEV

Stablecoin Development Corporation engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol. Its services intend to support protocol-level services, including staking, governance participation, validation, and related activities. The company was formerly known as NovaBay Pharmaceuticals, Inc. and changed its name to Stablecoin Development Corporation in April 2026. Stablecoi... [Read more]

Sector Financials
Founded 2000
Employees 4
Stock Exchange NYSEAMERICAN
Ticker Symbol SDEV
Full Company Profile

Financial Performance

Financial Statements

News

Stablecoin Development Corporation Reports First Quarter 2026 Financial Results

Company Generated $22.3 Million of Operating Income and Reported $552.4 Million of GAAP Net Income, Including Significant Non-Cash Warrant-Related Gains

9 days ago - GlobeNewsWire

Stablecoin Development Quarterly report: Q1 2026

Stablecoin Development has published its Q1 2026 quarterly earnings report on May 20, 2026.

9 days ago - Filings

Stablecoin Development Earnings release: Q1 2026

Stablecoin Development released its Q1 2026 earnings on May 20, 2026, summarizing the period's financial results.

9 days ago - Filings

Stablecoin Development Corporation Begins Trading on NYSE American Under Ticker “SDEV”

Company Announces Completion of Corporate Name Change and Provides Updated SKY Holdings and Staking Metrics Company Announces Completion of Corporate Name Change and Provides Updated SKY Holdings and ...

7 weeks ago - GlobeNewsWire

NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update

Following $134 million investment from R01 Fund LP, Framework Ventures, Tether Investments, S.A. de C.V., and Sky Frontier Foundation, Stablecoin Development Corporation has acquired  2.06 billion SKY...

2 months ago - GlobeNewsWire

Stablecoin Development Annual report: Q4 2025

Stablecoin Development has published its Q4 2025 annual report on March 19, 2026.

2 months ago - Filings

Stablecoin Development Transcript: EGM 2026

Six proposals were presented and approved, including major share issuances, amendments to the certificate of incorporation, and a new equity incentive plan. Quorum was established with over 96% voting power represented, and the meeting concluded with a Q&A session.

2 months ago - Transcripts

Stablecoin Development Proxy statement: Proxy Filing

Stablecoin Development filed a proxy statement on March 2, 2026, providing details for shareholder voting and corporate governance matters.

3 months ago - Filings

Stablecoin Development Proxy statement: Proxy Filing

Stablecoin Development filed a proxy statement on February 10, 2026, providing details for shareholder voting and corporate governance matters.

3 months ago - Filings

Stablecoin Development Proxy statement: Proxy Filing

Stablecoin Development filed a proxy statement on January 30, 2026, providing details for shareholder voting and corporate governance matters.

4 months ago - Filings

Stablecoin Development Registration statement: Registration Filing

Stablecoin Development filed a registration statement on November 25, 2025, providing details about a securities offering with the SEC.

6 months ago - Filings

Stablecoin Development Quarterly report: Q3 2025

Stablecoin Development has published its Q3 2025 quarterly earnings report on November 7, 2025.

7 months ago - Filings

NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards

EMERYVILLE, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) ("NovaBay" or the "Company") announces that it has regained compliance with the NYSE American's...

7 months ago - GlobeNewsWire

Stablecoin Development Proxy statement: Proxy Filing

Stablecoin Development filed a proxy statement on October 9, 2025, providing details for shareholder voting and corporate governance matters.

8 months ago - Filings

Stablecoin Development Registration statement: Registration Filing

Stablecoin Development filed a registration statement on October 3, 2025, providing details about a securities offering with the SEC.

8 months ago - Filings

Stablecoin Development Proxy statement: Proxy Filing

Stablecoin Development filed a proxy statement on September 23, 2025, providing details for shareholder voting and corporate governance matters.

8 months ago - Filings

NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting

EMERYVILLE, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (the “Company”) previously announced a one-time special cash dividend of $0.80 per share for ...

9 months ago - GlobeNewsWire

Stablecoin Development Proxy statement: Proxy Filing

Stablecoin Development filed a proxy statement on September 18, 2025, providing details for shareholder voting and corporate governance matters.

9 months ago - Filings

Stablecoin Development Proxy statement: Proxy Filing

Stablecoin Development filed a proxy statement on September 10, 2025, providing details for shareholder voting and corporate governance matters.

9 months ago - Filings

NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share

EMERYVILLE, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces its Board of Directors and the Special Transaction Comm...

9 months ago - GlobeNewsWire

NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar

Investment to support NovaBay's continued public listing and provide funding for a future strategic transaction Investment to support NovaBay's continued public listing and provide funding for a futur...

10 months ago - GlobeNewsWire

Stablecoin Development Quarterly report: Q2 2025

Stablecoin Development has published its Q2 2025 quarterly earnings report on August 14, 2025.

10 months ago - Filings

Stablecoin Development Quarterly report: Q1 2025

Stablecoin Development has published its Q1 2025 quarterly earnings report on May 14, 2025.

1 year ago - Filings

Stablecoin Development Annual report: Q4 2024

Stablecoin Development has published its Q4 2024 annual report on April 2, 2025.

1 year ago - Filings

Stablecoin Development Proxy statement: Proxy Filing

Stablecoin Development filed a proxy statement on March 19, 2025, providing details for shareholder voting and corporate governance matters.

1 year ago - Filings